We are live on
!
Find out more
BL
Bleichroeder LP Portfolio holdings
AUM
$559M
Turnover
17.24%
1-Year Est. Return
83.7%
This Fund
S&P 500
This Quarter
Est. Return
+2.82%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$460M
AUM Growth
-$19.1M
(-4%)
Cap. Flow
-$3.4M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
71.83%
Holding
94
New
1
Increased
7
Reduced
8
Closed
8
Avg Time Held
2
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
1.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Milestone Pharmaceuticals
MIST
|
+$4.28M |
| 2 |
Marinus Pharmaceuticals, Inc
MRNS
|
+$2.7M |
| 3 |
Cue Biopharma
CUE
|
+$934K |
| 4 |
OptiNose
OPTN
|
+$666K |
| 5 |
GPGI Inc
GPGI
|
+$281K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
+$5.24M |
| 2 |
Linde
LIN
|
+$3.76M |
| 3 |
HCAR
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
|
+$1.49M |
| 4 |
Celcuity
CELC
|
+$502K |
| 5 |
BK Technologies
BKTI
|
+$481K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.02% |
| 2 | Healthcare | 18.61% |
| 3 | Miscellaneous | 17.76% |
| 4 | Industrials | 15.02% |
| 5 | Financials | 13.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CORS.WS
51
DELISTED
Corsair Partnering Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CORS.WS
| $137K | 0.03% |
416,666
| – | – |
2021 Q3
5 quarters
|
|
52
Liberty Latin America Class C
LILAK
$1.6B
| $126K | 0.03% |
18,174
| – | – |
2020 Q2
10 quarters
|
|
53
ExxonMobil
XOM
$719B
| $119K | 0.03% |
1,075
| – | – |
2020 Q2
10 quarters
|
|
54
Bank of New York Mellon
BNY
$96.2B
| $91K | 0.02% |
2,000
| – | – |
2020 Q1
11 quarters
|
|
55
iSpecimen
ISPC
$2.54M
| $90.5K | 0.02% |
82
| – | – |
2021 Q2
6 quarters
|
|
|
LGF.B
56
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $89.1K | 0.02% |
16,413
| – | – |
2019 Q4
12 quarters
|
|
57
Cadence Design Systems
CDNS
$88.4B
| $84.3K | 0.02% |
525
| – | – |
2020 Q2
10 quarters
|
|
58
AbbVie
ABBV
$505B
| $83.2K | 0.02% |
515
| – | – |
2020 Q2
10 quarters
|
|
59
DELISTED
CompoSecure Inc Warrant
CMPOW
| $70K | 0.02% |
100,000
| – | – |
2022 Q1
3 quarters
|
|
60
Advanced Micro Devices
AMD
$900B
| $59.2K | 0.01% |
913
| – | – |
2022 Q1
3 quarters
|
|
61
Altria Group
MO
$123B
| $54.9K | 0.01% |
1,200
| – | – |
2020 Q2
10 quarters
|
|
|
EQRXW
62
DELISTED
EQRx, Inc. Warrant
EQRXW
| $53.6K | 0.01% |
200,000
| – | – |
2021 Q2
6 quarters
|
|
63
Teradyne
TER
$52.6B
| $52.4K | 0.01% |
600
| – | – |
2020 Q2
10 quarters
|
|
64
X4 Pharmaceuticals
XFOR
$252M
| $35.5K | 0.01% |
1,191
| – | – |
2019 Q4
12 quarters
|
|
65
Lumentum
LITE
$76.8B
| $34.4K | 0.01% |
660
| – | – |
2020 Q2
10 quarters
|
|
66
AT&T
T
$161B
| $30.4K | 0.01% |
1,650
| – | – |
2020 Q2
10 quarters
|
|
67
Liberty Latin America Class A
LILA
$1.61B
| $30.2K | 0.01% |
5,913
| – | – |
2020 Q1
11 quarters
|
|
68
DELISTED
OppFi Inc Warrants
OPFI.WS
| $25K | 0.01% |
250,000
| – | – |
2021 Q3
5 quarters
|
|
69
ARK Genomic Revolution ETF
ARKG
$2.08B
| $23.3K | 0.01% |
825
| – | – |
2022 Q1
3 quarters
|
|
70
ARK Blockchain & Fintech Innovation ETF
ARKF
$902M
| $17.1K | ﹤0.01% |
1,200
| – | – |
2022 Q1
3 quarters
|
|
71
Alliance Entertainment Holding Corp Warrants
AENTW
| $14.2K | ﹤0.01% |
200,000
| – | – |
2021 Q2
6 quarters
|
|
|
EQRX
72
DELISTED
EQRx, Inc. Common Stock
EQRX
| $12.3K | ﹤0.01% |
5,000
| – | – |
2022 Q1
3 quarters
|
|
73
SaverOne 2014 Ltd Warrant
SVREW
| $12.1K | ﹤0.01% |
121,000
| – | – |
2022 Q2
2 quarters
|
|
74
ARK Next Generation Technology ETF
ARKW
$2.22B
| $11.6K | ﹤0.01% |
300
| – | – |
2022 Q1
3 quarters
|
|
|
FAZEW
75
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
| $9.46K | ﹤0.01% |
75,000
| – | – |
2021 Q2
6 quarters
|
|
Similar funds
NFW
SCM
PHC
EPM
BCM
FAM
WDG
OC
Bleichroeder LP's Q4 2022 Portfolio in Review
As of Q4 2022, Bleichroeder LP held 94 positions worth $460M, down 4% from $479M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Bleichroeder LP's Q4 2022 filing shows 1 new, 7 increased, 8 reduced and 8 closed positions. Its largest new stake was Xperi: 34 shares worth $293. The largest sale was Tricida, Inc. Common Stock, an estimated $5.24M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Miscellaneous.
- Bleichroeder LP's largest Q4 2022 buy was Xperi: 34 shares worth $293.
- Bleichroeder LP added most to Milestone Pharmaceuticals in Q4 2022, an estimated $4.28M increase.
- Bleichroeder LP's biggest Q4 2022 reduction was Linde, cutting an estimated $3.76M.
- Bleichroeder LP fully exited Tricida, Inc. Common Stock in Q4 2022, selling an estimated $5.24M.
- Bleichroeder LP's ten largest holdings make up 72% of its $460M portfolio in Q4 2022.
- Bleichroeder LP opened 1 new position and closed 8 in Q4 2022.
- Bleichroeder LP's portfolio value fell 4% quarter-over-quarter to $460M.
Based on Bleichroeder LP's 13F filing for Q4 2022, filed 14 Feb 2023.